Wagner, J., Yuen, L., Littlejohn, M., Sozzi, V., Jackson, K., Martin, R., Aeschbacher, T., Suri, V., Tan, S. K., Feierbach, B., Gaggar, A., Marcellin, P., Buti Ferret, M., Janssen, H. L. A., Gane, E., Meagher, N., Price, D. J., Wong, D., Thompson, A. T., & Revill, P. A. (2023). hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B. Alimentary pharmacology & therapeutics, 57(5), 509–523. http://access.bl.uk/ark:/81055/vdc_100177581320.0x000056